{"url_path":"/sec/pure/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-03-17","source_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-010385-index.html","accession_number":"0001493152-26-010385","cik":"0001006028","ticker":"PURE","issuer_name":"PURE BIOSCIENCE, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-010385-index.html","primary_entity_key":"0001006028","primary_entity_name":"PURE BIOSCIENCE, INC."},"word_count":115,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nFrom\ntime to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of our business. The\nimpact and outcome of litigation, if any, is subject to inherent uncertainties, and any adverse result in these or other matters may\narise from time to time that could harm our business. We are not currently aware of any such legal proceedings or claims to which we\nor our wholly owned subsidiary is a party or of which any of our property is subject that we believe will have, individually or in the\naggregate, a material adverse effect on our business, financial condition or results of operations."}